Rezo Therapeutics
South San Francisco
About Rezo Therapeutics
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $78.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: rezotx.space
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Product Research
Social Profiles
Canonical: https://fsome.com/organization/rezo-therapeutics-31493 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.